Table 3.
Parameter | Control Group | Treatment Group | P |
---|---|---|---|
Hemoglobin (g/dl) (mean ± SD)a | 10.7±1.5 | 11.0±1.2 | 0.001b |
ESA dose (IU/wk) (median [min,max]) | 2000 [0,29000] | 2000 [0, 35000] | 0.05c |
Iron dose (mg/wk) (median [min,max]) | 0 [0,300] | 0 [0,300] | 0.71c |
TSAT (%) (mean ± SD) | 30.1±13.13 | 31.6±10.5 | 0.12b |
Ferritin (ng/ml) (median ± interquartile range) | 905±611 | 868±662 | 0.08c |
Central tendency and dispersion measures are computed across all study participants over 12 months follow-up period.
Primary outcome.
t test.
Independent samples median test.